Relationship of obesity to adverse events in myocardial infarction patients without primary percutaneous coronary intervention: results from the Occluded Artery Trial (OAT)

References

• Joyce E, Hoogslag GE, Kamperidis V, et al. Relationship between myocardial function, body mass index, and outcome after ST-segment-elevation myocardial infarction. Circ Cardiovasc Imaging. 2017;10:e005670.
   PubMed Web of Science ®Google Scholar
• Holroyd EW, Sirker A, Kwok CS, et al. The relationship of body mass index to percutaneous coronary intervention outcomes: does the obesity paradox exist in contemporary percutaneous coronary intervention cohorts? Insights from the British Cardiovascular Intervention Society Registry. JACC Cardiovasc Interv. 2017;10:1283–1292.
   PubMed Web of Science ®Google Scholar
• Romero-Corral A, Montori VM, Somers VK, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006;368:666–678.
   PubMed Web of Science ®Google Scholar
• Azhari Z, Ismail MD, Zuhdi ASM, et al. Association between body mass index and outcomes after percutaneous coronary intervention in multiethnic south east Asian population: a retrospective analysis of the Malaysian National Cardiovascular Disease Database–Percutaneous Coronary Intervention (NCVD-PCI) registry. BMJ Open. 2017;7:e017794.
   PubMed Web of Science ®Google Scholar
• Angeras O, Albertsson P, Karason K, et al. Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish Coronary Angiography and Angioplasty Registry. Eur Heart J. 2013;34:345–353.
   PubMed Web of Science ®Google Scholar
• Bechlioulis A, Vakalis K, Naka KK, et al. Paradoxical protective effect of central obesity in patients with suspected stable coronary artery disease. Obesity. 2013;21:E314–E321.
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Arena R, Alpert MA, et al. Management of cardiovascular diseases in patients with obesity. Nat Rev Cardiol. 2018;15:45–56.
   PubMed Web of Science ®Google Scholar
• Elagizi A, Kachur S, Lavie CJ, et al. An overview and update on obesity and the obesity paradox in cardiovascular diseases. Prog Cardiovasc Dis. 2018;61:142–150.
   PubMed Web of Science ®Google Scholar
• Filgueiras Filho NM, Feitosa Filho GS, Solla D, et al. Implementation of a regional network for ST-segment-elevation myocardial infarction (STEMI) care and 30-day mortality in a low- to middle-income city in Brazil: findings from Salvador's STEMI Registry (RESISST). J Am Heart Assoc. 2018;7(14):e008624.
   PubMed Web of Science ®Google Scholar
• Huber K, Goldstein P, Danchin N, et al. Enhancing the efficacy of delivering reperfusion therapy: A European and North American experience with ST-segment elevation myocardial infarction networks. Am Heart J. 2013;165:123–132.
   PubMed Web of Science ®Google Scholar
• Hochman JS, Lamas GA, Knatterud GL, et al. Design and methodology of the Occluded Artery Trial (OAT). Am Heart J. 2005;150:627–642.
   PubMed Web of Science ®Google Scholar
• Hochman JS, Lamas GA, Buller CE, et al. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med. 2006;355:2395–2407.
   PubMed Web of Science ®Google Scholar
• Hou X, Liu Y, Lu H, et al. Ten-year changes in the prevalence of overweight, obesity and central obesity among the Chinese adults in urban Shanghai, 1998–2007 – comparison of two cross-sectional surveys. BMC Public Health. 2013;13:1064.
   PubMed Web of Science ®Google Scholar
• Flegal KM, Carroll MD, Kit BK, et al. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA. 2012;307:491–497.
   PubMed Web of Science ®Google Scholar
• Gruberg L, Weissman NJ, Waksman R, et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol. 2002;39:578–584.
   PubMed Web of Science ®Google Scholar
• Gurm HS, Brennan DM, Booth J, et al. Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox). Am J Cardiol. 2002;90:42–45.
   PubMed Web of Science ®Google Scholar
• Benderly M, Boyko V, Goldbourt U. Relation of body mass index to mortality among men with coronary heart disease. Am J Cardiol. 2010;106:297–304.
   PubMed Web of Science ®Google Scholar
• Abi Khalil C, Sulaiman K, Singh R, et al. BMI is inversely correlated to the risk of mortality in patients with type 2 diabetes hospitalized for acute heart failure: findings from the Gulf Acute Heart Failure (gulf-CARE) Registry. Int J Cardiol. 2017;241:262–269.
   PubMed Web of Science ®Google Scholar
• Kokkinos P, Myers J, Faselis C, et al. BMI-mortality paradox and fitness in African American and Caucasian men with type 2 diabetes. Diabetes Care. 2012;35:1021–1027.
   PubMed Web of Science ®Google Scholar
• Curtis JP, Selter JG, Wang Y, et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med. 2005;165:55–61.
   PubMed Web of Science ®Google Scholar
• Bucholz EM, Rathore SS, Reid KJ, et al. Body mass index and mortality in acute myocardial infarction patients. Am J Med. 2012;125:796–803.
   PubMed Web of Science ®Google Scholar
• Vareldzis R, Naljayan M, Reisin E. The incidence and pathophysiology of the obesity paradox: should peritoneal dialysis and kidney transplant be offered to patients with obesity and end-stage renal disease? Curr Hypertens Rep. 2018;20:84.
   PubMed Web of Science ®Google Scholar
• Carnethon MR, De Chavez PJ, Biggs ML, et al. Association of weight status with mortality in adults with incident diabetes. JAMA. 2012;308:581–590.
   PubMed Web of Science ®Google Scholar
• Sliwa K, Lee GA, Carrington MJ, et al. Redefining the ECG in urban South Africans: electrocardiographic findings in heart disease-free Africans. Int J Cardiol. 2013;167:2204–2209.
   PubMed Web of Science ®Google Scholar
• Gurm HS, Whitlow PL, Kip KE, et al. The impact of body mass index on short- and long-term outcomes inpatients undergoing coronary revascularization. Insights from the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol. 2002;39:834–840.
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Laddu D, Arena R, et al. Healthy weight and obesity prevention: JACC health promotion series. J Am Coll Cardiol. 2018;72:1506–1531.
   PubMed Web of Science ®Google Scholar
• Fadl YY, Krumholz HM, Kosiborod M, et al. Predictors of weight change in overweight patients with myocardial infarction. Am Heart J. 2007;154:711–717.
   PubMed Web of Science ®Google Scholar
• Moholdt T, Lavie CJ, Nauman J. Interaction of physical activity and body mass index on mortality in coronary heart disease: data from the Nord-Trondelag Health Study. Am J Med. 2017;130:949–957.
   PubMed Web of Science ®Google Scholar
• Moholdt T, Lavie CJ, Nauman J. Sustained physical activity, not weight loss, associated with improved survival in coronary heart disease. J Am Coll Cardiol. 2018;71:1094–1101.
   PubMed Web of Science ®Google Scholar
• Barry VW, Caputo JL, Kang M. The joint association of fitness and fatness on cardiovascular disease mortality: a meta-analysis. Prog Cardiovasc Dis. 2018;61:136–141.
   PubMed Web of Science ®Google Scholar
• Kennedy AB, Lavie CJ, Blair SN. Fitness or fatness: which is more important? JAMA. 2018;319:231–232.
   PubMed Web of Science ®Google Scholar
• Ozemek C, Laddu DR, Lavie CJ, et al. An update on the role of cardiorespiratory fitness, structured exercise and lifestyle physical activity in preventing cardiovascular disease and health risk. Prog Cardiovasc Dis. 2018;61:484–490.
   PubMed Web of Science ®Google Scholar
• Fletcher GF, Landolfo C, Niebauer J, et al. Promoting physical activity and exercise: JACC health promotion series. J Am Coll Cardiol. 2018;72:1622–1639.
   PubMed Web of Science ®Google Scholar